Zenas BioPharma CEO Lonnie Moulder bought $1.64M in ZBIO stock after a 52% crash. His track record: $10B+ in biotech exits including TESARO sold to GSK.

Zenas BioPharma CEO Bets $1.64M on Stock After 52% Crash—His Track Record: $10 Billion in Exits

Zenas BioPharma CEO bought $1.64M in stock over 3 days after positive Phase 3 data crashed shares 52%. Stock now up 40% from lows.

Zenas BioPharma CEO Buys $1.64M in Stock Days After Phase 3 Win Triggered 52% Crash

Zenas BioPharma CEO Lonnie Moulder buys $1.63M in ZBIO stock after 52% crash. Serial biotech founder with $9B in exits bets on his own company.

Zenas BioPharma (ZBIO)·Earnings Reports

Q3 2025

Q2 2025

Q1 2025

Q4 2024

Analyst Coverage

Recent News about Zenas BioPharma

Zenas BioPharma CEO Bets $1.64M on Stock After 52% Crash—His Track Record: $10 Billion in Exits

Zenas BioPharma CEO Buys $1.64M in Stock Days After Phase 3 Win Triggered 52% Crash

Zenas BioPharma CEO Buys $1.6M in Stock After 52% Crash